Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a... see more

TSX:SVA - Post Discussion

Sernova Corp > Management Information Circular (not included)
View:
Post by donkeyfeathers on Jun 08, 2021 2:21pm

Management Information Circular (not included)

In the proxy package mailout (at least with what was mailed to me).  Here's something interesting from that circular (on SEDAR):

Material Terms of Incentive Plan, as amended and restated

Following approval, the material terms of the Incentive Plan, as amended and restated, will be as follows:

  •  The Common Share reserve is a fixed aggregate maximum of 15% of the outstanding Common Shares as of May 14, 2021 pursuant to the Incentive Plan as amended and restated on May 14, 2021, being 38,746,536 Common Shares allocated in reserve as: (i) a maximum of 7,749,307 Common Shares for issuance upon conversion of DSUs pursuant to the DSU Plan; and (ii) the balance of 30,997,229 Common Shares for exercise of Options granted pursuant to the Option Plan.

  •  The maximum number of Common Shares that may be issued under the Incentive Plan, as amended, and pursuant to all of the Corporation’s security-based compensation arrangements is increased to the new aggregate maximum of 38,746,536 Common Shares, and is subject to the following limitations:

(This doesn't format correctly when pasting...so go have a look)

  •  The Incentive Plan is administered by the Board with input from the Compensation Committee.

  •  Options may be granted to Directors, Officers, Employees, Management Company Employees, Consultants or

    Company Consultants (as such are defined in TSXV policies and referred to in the Incentive Plan, as amended).

  •  DSU awards may be granted to directors and officers but the Board has discretion (without further shareholder approval) to expand awards to other eligible participants, including Employees, Management Company Employees, Consultants or Company Consultants (as such are defined in TSXV policies).

We all get to have our vote (#4) on the Amend and Restate Incentive Plan Deferred Share Unit Component.  I suggest having a close look.  I won't get into the implications of the way compensation is structured here, but it doesn't take a genius to figure out that "long term thinking" is a relative term, and who in the end would want to get their compensation in shares, in salary, or...be able to string this idea along for as long as possible, if that enriched you (personally) the most.
DF
Comment by cowjazz on Jun 08, 2021 6:35pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities